Published in Am J Transplant on November 01, 2009
Bortezomib in Late Antibody-mediated Kidney Transplant Rejection (BORTEJECT) | NCT01873157
The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol (2012) 1.71
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Cryptic B cell response to renal transplantation. Am J Transplant (2013) 1.57
Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant (2014) 1.29
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. Am J Transplant (2014) 1.19
Germinal center alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells. J Immunol (2012) 1.08
Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients. J Am Soc Nephrol (2014) 0.96
Regulation of allograft survival by inhibitory FcγRIIb signaling. J Immunol (2012) 0.94
Utility of HLA Antibody Testing in Kidney Transplantation. J Am Soc Nephrol (2015) 0.93
Quantifying renal allograft loss following early antibody-mediated rejection. Am J Transplant (2015) 0.88
The generation and maintenance of serum alloantibody. Curr Opin Immunol (2010) 0.88
Chronic alloantibody mediated rejection. Semin Immunol (2011) 0.87
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial. Trials (2014) 0.87
Is it time to give up with calcineurin inhibitors in kidney transplantation? World J Transplant (2013) 0.86
Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited. Transplantation (2012) 0.85
Molecular assessment of disease states in kidney transplant biopsy samples. Nat Rev Nephrol (2016) 0.85
Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts. Transpl Immunol (2012) 0.84
Unlinked memory helper responses promote long-lasting humoral alloimmunity. J Immunol (2012) 0.83
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation (2015) 0.83
Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients. Transplantation (2014) 0.83
Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update. Biologics (2012) 0.83
Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies. Stem Cells Transl Med (2013) 0.83
MICA variant promotes allosensitization after kidney transplantation. J Am Soc Nephrol (2013) 0.83
Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation. Clin Dev Immunol (2013) 0.82
Ischemia-reperfusion injury accelerates human antibody-mediated transplant vasculopathy. Transplantation (2013) 0.82
Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms. Am J Transplant (2015) 0.82
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study. Am J Transplant (2016) 0.82
Antibody induction therapy in adult kidney transplantation: A controversy continues. World J Transplant (2012) 0.81
Late kidney dysfunction in a kidney transplant recipient. Clin J Am Soc Nephrol (2013) 0.80
Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation. Am J Transplant (2014) 0.80
The specificity of acute and chronic microvascular alterations in renal allografts. Clin Transplant (2013) 0.79
Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts. J Am Soc Nephrol (2016) 0.78
Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection. Transplantation (2012) 0.78
The Natural History of Kidney Graft Cortical Microcirculation Determined by Real-Time Contrast-Enhanced Sonography (RT-CES). PLoS One (2016) 0.78
Capillary deposition of complement C4d and C3d in Chinese renal allograft biopsies. Dis Markers (2015) 0.77
Correlation of histopathologic and dynamic tissue perfusion measurement findings in transplanted kidneys. BMC Nephrol (2013) 0.77
Clinical relevance of HLA antibody monitoring after kidney transplantation. J Immunol Res (2014) 0.77
Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy. World J Transplant (2014) 0.77
Evaluation of the highly sensitized transplant recipient. Pediatr Nephrol (2011) 0.76
Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal. J Transplant (2011) 0.76
The Value of Protocol Biopsies to Identify Patients with De Novo Donor Specific Antibody at High Risk for Allograft Loss. Am J Transplant (2016) 0.75
Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA. PLoS One (2015) 0.75
Posttransplant allosensitization in low immunological risk kidney and kidney-pancreas graft recipients. Biomed Res Int (2014) 0.75
Desensitization: Overcoming the Immunologic Barriers to Transplantation. J Immunol Res (2017) 0.75
Immunosenescence in renal transplantation: a changing balance of innate and adaptive immunity. Curr Opin Organ Transplant (2015) 0.75
Fcγ Receptors in Solid Organ Transplantation. Curr Transplant Rep (2016) 0.75
Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients. Medicine (Baltimore) (2016) 0.75
Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians. Transplantation (2016) 0.75
Transplantology: Challenges for Today. Arch Immunol Ther Exp (Warsz) (2017) 0.75
Humoral antibodies in organ transplantation: angels or demons? Am J Transplant (2010) 0.75
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients. J Immunol Res (2017) 0.75
Involvement of indirectly allostimulated CD4+CD43highCD45RO+ T cell proliferation in the development of chronic allograft nephropathy. Exp Biol Med (Maywood) (2015) 0.75
Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants. Front Med (Lausanne) (2017) 0.75
A C. elegans mutant that lives twice as long as wild type. Nature (1993) 20.42
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet (1998) 5.35
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill. Canadian Critical Care Trials Group. JAMA (1995) 3.08
Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol (2002) 3.05
Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res (2000) 3.03
Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med (1993) 2.96
Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol Cell (2000) 2.76
Tolerance versus immunosuppression: a perspective. Am J Transplant (2008) 2.71
Use of minicells for bacteriophage-directed polypeptide synthesis. Methods Enzymol (1979) 2.64
Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int (2000) 2.52
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet (2000) 2.50
Reliability of information abstracted from patients' medical records. Med Care (1978) 2.49
Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst (1994) 2.45
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Whole-gut irrigation in preparation for large-bowel surgery. Lancet (1973) 2.39
Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum (1975) 2.30
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J (1980) 2.29
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol (1998) 2.18
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation (2001) 2.03
Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J Biol Chem (2000) 1.98
Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J (1998) 1.97
FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant (2008) 1.94
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care (1996) 1.91
Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol (2000) 1.89
Altering telomere structure allows telomerase to act in yeast lacking ATM kinases. Curr Biol (2001) 1.89
The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab (1997) 1.87
Broken rotational symmetry in the pseudogap phase of a high-T(c) superconductor. Nature (2010) 1.82
Enamel surfaces after orthodontic bracket debonding. Angle Orthod (1995) 1.80
A single amino acid substitution converts a carboxylesterase to an organophosphorus hydrolase and confers insecticide resistance on a blowfly. Proc Natl Acad Sci U S A (1997) 1.76
Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76
Selection of axial growth sites in yeast requires Axl2p, a novel plasma membrane glycoprotein. Genes Dev (1996) 1.75
Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet (1976) 1.73
Nationwide survey of human parasite in China. Southeast Asian J Trop Med Public Health (1994) 1.72
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
The distribution, determinants, and clinical correlates of vertebral osteophytosis: a population based survey. J Rheumatol (1999) 1.60
The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant (2011) 1.60
CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer (2002) 1.59
Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation (1995) 1.59
Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J Biol Chem (1997) 1.58
Phylogenetic analysis of 18 thermophilic Methanobacterium isolates supports the proposals to create a new genus, Methanothermobacter gen. nov., and to reclassify several isolates in three species, Methanothermobacter thermautotrophicus comb. nov., Methanothermobacter wolfeii comb. nov., and Methanothermobacter marburgensis sp. nov. Int J Syst Evol Microbiol (2000) 1.58